Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 12953136 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| unrelated hematopoietic stem cell transplantation (hsct) is a recognized therapy for hematological diseases and over 8 million hla-typed donors are ready to donate. | |||||||
| 15555258 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematological diseases | NA | NA | NA | unclassified | |
| to explore the clinical application of human leukocyte antigen (hla) mismatched hematopoietic stem cell transplantation (hsct) for malignant hematological diseases using a new giac protocol. | |||||||
| 15555258 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| to explore the clinical application of human leukocyte antigen (hla) mismatched hematopoietic stem cell transplantation (hsct) for malignant hematological diseases using a new giac protocol. | |||||||
| 16638208 | HLA (HLA) | hematological diseases | NA | NA | NA | unclassified | |
| 373 consecutive patients with hematological diseases received family hla matched or mismatched hct from may, 2002 to july, 2004. | |||||||
| 17074143 | HLA MATCHED (HLA-MATCHED) | mycophenolate | NA | methotrexate | NA | unclassified | |
| NA | |||||||
| 19080474 | HLA MATCHED (HLA-MATCHED) | prednisone | NA | methotrexate | NA | unclassified | |
| NA | |||||||
| 19919293 | HLA IDENTICAL (HLA-IDENTICAL) | cyclophosphamide | NA | methotrexate | NA | only_studied | |
| NA | |||||||
| 20121594 | HLA MATCHED (HLA-MATCHED) | hematological diseases | NA | NA | NA | unclassified | |
| allogeneic hematopoietic stem cell transplantation (allo-sct) from an hla-matched related or unrelated donor is a curative option for patients with high-risk hematological diseases. | |||||||
| 20121594 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| allogeneic hematopoietic stem cell transplantation (allo-sct) from an hla-matched related or unrelated donor is a curative option for patients with high-risk hematological diseases. | |||||||
| 24989292 | HLA (HLA) | hematological diseases | NA | NA | NA | unclassified | |
| it is concluded that hla-4-6/6 loci matched ucbt is an effective option to treat hematological diseases. | |||||||
Copyright 2024